Archive
Proactive news snapshot: ReNeuron Group PLC, Tissue Regenix Group PLC, ANGLE PLC, Motif Bio PLC …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
ReNeuron Group PLC
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 2 of 3
Investments and investor services
FTSE 100 closes in positive territory, boosted by better-than-expected US March jobs figures as Brexit uncertainty continues
Mid-cap cousin FTSE 250 was also lower, shedding around 56 points at 19,507
Archive
Proactive news snapshot: WideCells Group, Tlou Energy, Oriole Resources, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron starts dosing second cohort in eye disease trial
The company's retinitis pigmentosa clinical programme benefits from orphan drug designation in both Europe and the US, as well as a fast track designation from the FDA in the US
Archive
Small cap movers: Cracks appear in Purplebricks as US and UK bosses exit amid profit warning
A look back at some of the more interesting stories from the junior market over the past week
Mobile Tornado shares blown higher on back of solid trading update
Some of the major news-driven risers and fallers on Wednesday …
Archive
Proactive news snapshot: ReNeuron, Bango, Landore Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron shares spike 20% after it provides encouraging update to Phase II eye disease trial
The first three patients in a group taking part in the Phase II portion of the study were able on average able to read an additional three lines of on the standard ETDRS eye chart after receiving treatment
FTSE 100 closes higher as markets more optimistic on US, China trade
BIg banking group Lloyds was among the top gainers on Footsie
Archive
Proactive news snapshot: BigDish, ValiRx, Oriole Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sylvania Platinum fails to flatten 'em - the sceptics, that is - with its production update
A look at the day's major movers, including Cambridge Cognition, SRT Marine, Redhall, FireAngel, Challenger Acquisitions, Alexander Mining and Blue Star Capital
ReNeuron partner to unveil production scale-up data
Dr Nicola Goddard, of University College London, and her team have made a significant advance in the manufacture of exosomes, which are nanoparticles released by cells
Archive
Proactive news snapshot: Primary Health Properties, Circassia Pharmaceuticals, Shield Therapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
AorTech in good heart
A look at the day's major movers, including Tri-Star Resources, Quixant, Metals Exploration, NCC Group, Primary Health Properties, MedicX Fund, Nautical Marine Services, Blue Star Capital and Gama Aviation.
First person treated in ReNeuron’s mid-stage US stroke trial
ReNeuron has developed CTX – a stem cell therapy that it believes can help improve the quality of life for people left disabled by a stroke
Biotech CEOs gather in San Francisco to mull 2019 outlook
On the agenda at this year's Biotech Showcase is a panel discussion entitled “Cell and gene therapy: The financing surge” featuring Orgenesis CEO Vered Caplan
Investments and investor services
Aminex bounces higher as shareholders approve farm-out
A look at the day's major movers, including ReNeuron, 7digital, Glenveagh, Gear4Music, Reach and McColl's
Archive
Proactive news snapshot: Remote Monitored Systems, ReNeuron, Circassia Pharmaceuticals …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron signs exosome collaboration deal with US biopharma
The unnamed US-based company will explore the use of exosomes as a potential delivery vehicle for synthetic oligonucleotides used in gene therapy
Archive
Proactive news snapshot: Block Energy, ReNeuron Group, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Science Group takes down the 'for sale' sign
A look at the day's major movers, including Photonstar, Capita, IHG, GVC, Reach and Balfour Beatty
ReNeuron primed for significant clinical progress
The company has two clinical trials underway and is well funded to achieve its immediate ambitions
Investments and investor services
FTSE 100 closes lower as China and Europe worries sends global equities down
Barratt Developments lost 2.69 points at 440.50p , while Persimmon also dropped 2.69% at 1,897p.
Archive
Balfour Beatty investors looking for more reassurance in Friday’s update
The penultimate Friday looks unsurprisingly like being a quiet one, but Balfour Beatty is due to publish a trading update and investors will be looking for more reassurance from the contractor
Archive
All eyes on UK parliament as Brexit deal circus reaches final act
Aside from the crucial Brexit vote, the Week Ahead will also bring UK labour market data, an ECB council meetings and updates from TUI, WPP, Dixons Carphone, Superdry, Ocado and BAT
Archive
Proactive news snapshot: Wishbone Gold, ReNeuron Group, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Sativa Investments shares light up; discoverIE Group shares march higher
A look at some of the winner and losers in UK trading during Thursday's session
ReNeuron’s CTX stem cell platform could be used to fight cancer
ReNeuron thinks CTX could be reprogrammed and used to produce new non-donor-specific cell lines, including NK and T-Cells – the cells that can be modified to attack cancer cells
FTSE 100 closes in red as Wall Street shares lag; Brexit exhaustion
The UK blue-chip benchmark finished down over 27 points at 7,026, while the FTSE 250 closed down over 52 points at 18,961.
Archive
Proactive news snapshot: Pan African Resources, Strategic Minerals, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
ReNeuron to resume discussions with other potential suitors as US pharma group backs out
The unnamed group’s decision not to progress to a definitive licensing agreement had nothing to do with ReNeuron’s technology, the company said
Investments and investor services
FTSE 100 closes higher as trade fears ebb; Kingfisher leads the laggards
The FTSE 100 closed nearly 31 points higher at 7,331, while FTSE 250 added over 42 at 20,500
Water Intelligence shares in positive territory after strong first half performance
A look at some of the top risers and fallers in London on Wednesday
Archive
Proactive news snapshot: Erris Resources, Faron Pharma, Chariot Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron will begin clinical trial shortly; upbeat on potential deals
The cell technology group said the first of a group of 110 patients taking part in PICSE III will be enrolled soon
FTSE 100 closes higher with pound volatile, as tobacco stocks fire up on FDA move
The UK blue chip index rose 34 points to 7,308 around 3.40pm
Bellzone knocks out £1mln placing after recent share price surge
Some of the main news-driven risers and fallers in London on Thursday ...
Archive
Proactive news snapshot: AFC Energy, ADES International, Europa Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron Group well funded for the next phase of development
The cell therapy specialist also reported there had been industry interest around its main programmes
FTSE 100 closes higher Thursday as traders come back to equities
Sterling was also stronger - up 0.06% to 1.1318 against the Euro and up 0.12% versus the US dollar
Archive
ASOS set for a warm weather boost
Thursday will see retailers ASOS and Dunelm to the fore. The former is expected to issue an upbeat statement while the latter will be looking to prove it is not curtains for its growth story.
Patagonia Gold shares drop as it cuts full year production guidance
A look at some of the top risers and fallers in London on Wednesday
Archive
Proactive news snapshot: Solo Oil, Aminex, ReNeuron Group, ECR Minerals ...
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron stands to net an initial US$5mln as US company runs rule over its retinal stem cell technology
It has inked a three-month exclusivity deal with an unnamed American speciality pharma group
FTSE 100 tumbles 1.3% lower as trade worries grip markets
The UK blue chip index dropped 100 points after the US said it was ready to impose tariffs on an extra US$200bn worth of Chinese goods
Archive
Proactive news snapshot: Active Energy Group, Gfinity, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Red Emperor shares fall as it amends joint venture agreement with Oil Ventures
A look at some of the top risers and fallers in London on Thursday
Investments and investor services
FTSE 100 clocks off at new closing high
FTSE 100 closed at a new all time high on Thursday, up 0.70% to 7,787
Archive
Proactive news snapshot: ReNeuron Group, DP Poland, Minds + Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Tern, Tekcapital, and Minds Machines among Friday’s standout movers
A look at some of the biggest risers and fallers in London on Thursday.
ReNeuron Group head of research to present encouraging early data on potential cancer treatment
Dr Randolph Corteling will detail his findings at the 2018 International Society of Cell Therapy conference in Montreal
Investments and investor services
FTSE 100 strengthens following wishy-washy US jobs data
It's the first Friday of the month, so naturally much of the attention was on the US non-farm payroll report.
Archive
Proactive news snapshot: Telit Communications, Hummingbird Resources, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Small caps slide: Andalas, Velocity Composites and Ten Lifestyle
A look at some of the biggest risers and fallers in London on Monday.
Archive
Proactive news snapshot: ValiRx, Stratex International, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
MyCelx ups full-year guidance as new order and equipment sale bring in US$2.7mln
MYCELX now expects full-year revenues to be in the range of US$16-17mln after the new order and equipment sale
ReNeuron wins £1.5mln to fund further development of its hRPC cell therapy candidate
ReNeuron’s human retinal progenitor cell (hRPC) therapy is being developed as a treatment for blindness-causing eye diseases such as retinitis pigmentosa
FTSE 100 closes in the black as Shire surges; tobacco stocks drift lower
Shire shares ended 5.89% up as the group received and rejected a takeover approach from Japan's Takeda Pharma
ReNeuron appoints new chief medical officer based in recently established US office
The AIM-listed firm said Dr Richard Beckham will replace Dr Julian Howell, who has left the company to pursue another opportunity
Archive
Proactive news snapshot: Galileo Resources, ValiRx, ITM Power …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Instem, ANGLE, Stratex International …
A glance at some of the day's highlights from the Proactive Investors newswire
Milestone Group jumps as digital media company enters blockchain joint venture agreement
A look at some of the biggest risers and fallers in London on Monday
ReNeuron increases number of clinical sites in its PISCES III study
ReNeuron said it had taken the decision to increase the number of sites to ensure that patient recruitment targets in the study are met
FTSE 100 closes in red as pound firms but miners add support
Sterling added 0.01% against the Euro to 1.1434, while against the US dollar, it added 0.60% to 1.4232.
ReNeuron's CTX cells play a part in positive artificial nerve tissue study
This is the first time ReNeuron's CTX cells have been combined with an engineered support to guide nerve repair
Archive
Proactive news snapshot: Mosman Oil and Gas, Eland Oil & Gas, SDX Energy…
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: ReNeuron, AFC Energy, Amur Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Paternoster Resources hooks investors as it unveils bid to reduce costs
Proactive takes a look at the movers and shakers in London
ReNeuron Group presents positive stroke data to US conference
Lead investigator, Professor Keith Muir, updated on progress at the American Heart Association International Stroke Conference in Los Angeles
FTSE 100 clocks up 50 point gain despite strength of sterling
The dollar's revival did not last long, and although a weak dollar is regarded as being detrimental to the FTSE, the top-shares index still managed a 50 point gain
Archive
Proactive news snapshot: Kibo Mining, Mporium Group, Europa Oil & Gas ….
A glance at some of the day's highlights from the Proactive Investors newswire
Keller gains on US acquisition talks, also says Trump tax changes will benefit future earnings
Some of the main biggest risers and fallers in London on Friday
ReNeuron hopes share consolidation will improve the marketability and liquidity of the stock
The stem cell specialist said it wants to reduce its equity base by a factor of 100
FTSE 100 pops higher again to another record close
It was another quiet day in London but also another record close
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
ReNeuron receives approval from US authorities to kick off phase IIb stroke trial
Long-term data from the PISCES II trial earlier this year showed ReNeuron’s CTX cell therapy candidate has the potential to improve the disability of stroke patients
Investments and investor services
FTSE 100 finishes in the red as BoE keeps rates on hold
FTSE 100 closed down over 48 points at 7,448., while FTSE 250 shed over 55 to 20,006
Investments and investor services
Will Sports Direct International investors still be optimistic when interims come out on Thursday?
Sports Direct International, Ocado Group, PZ Cussons, and Bunzl are among the names in Thursday's agenda.
Archive
Proactive news snapshot: ANGLE, ReNeuron Group, Touchstone Exploration …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Federal Reserve Grinch to dominate among upcoming central bank rate decisions
The Week Ahead will be dominated by interest rate decisions from the US Federal Reserve, Bank of England and ECB, plus UK inflation and results from Ashtead Group, TUI, and Dixons Caphone among others
Dunlelm Group plc shares boosted by pre-Christmas note from Deutsche
Vela Technologies was a big riser in early deals in London
ReNeuron establishes Boston office ahead of US clinical trials
It will be a base for medical and scientific communications staff
Archive
Proactive news snapshot: Victoria Oil & Gas, Shanta Gold, Belvoir Lettings,Cabot Energy
A look at some of the day's highlights from the Proactive Investors newswire
ReNeuron jumps at opening bell as it gets green light to begin second part of phase I/II eye disease trial
Data from the phase II part of the phase I/II trial is expected in the second half of 2018, with readouts from the subsequent, larger phase IIb study due in 2020
ReNeuron making good progress with all of its key therapeutic programmes
As of March, ReNeuron had £53mln in cash equivalents but its market value is not too much above that....
Archive
Proactive news snapshot: Wolf Minerals , Sareum Holdings, ReNeuron Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Metminco rallies on quarterly update, Pantheon Resources shares fall on drilling difficulties
A look at some of the biggest risers and fallers in London today
ReNeuron boss “delighted” with long-term stroke data
“These positive long term results are highly encouraging, indicating that the CTX therapy has the potential to produce meaningful and sustained improvements in disability as well as motor function in disabled stroke patients”
FTSE 100 closes a shade higher as pound strengthens ahead of rate decision
Around 4pm, the UK blue chip index rose 2 points to 7,490
Archive
Proactive news snapshot: Kibo Mining, Symphony Environmental Technologies, ReNeuron …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron awarded new grant by Wales for exosome research
The grant, awarded under the SMARTExpertise scheme, will help fund a £1.2m collaborative programme of work
FTSE 100 ends the week on a firm note
The blue-chip index finished the day above the 7,500 level
Archive
Proactive news snapshot: Jersey Oil and Gas, Landore Resources, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire